European stock markets ended sharply lower on Tuesday after new data from China exacerbated concerns about the outlook for the world's second biggest economy.
The pan-European STOXX 600 provisionally closed 2.9 percent lower after weak manufacturing data from China fueled selling throughout the session.
Two sets of key Chinese data disappointed traders on Tuesday; the official manufacturing purchasing managers' index (PMI) edged down to 49.7 in August from 50 in July, while the final Caixin/Markit manufacturing PMI came in at 47.3 in August, down from 47.8 in July.
In Asia, stock markets also closed down across the board.
Prices of both Brent crude and WTI oil plummeted over 7 percent on the day, but the weakness came after a stunning rally over the past few days which has seen Brent back above $50 per barrel. Prices fell back towards $50 on Tuesday, with Brent for October delivery losing over $4 to trade just under $50.
Meanwhile, shares in London-listed hedge fund manager Man Group finished down almost 7 percent after the company's China business was taken into custody to help authorities probe the recent market volatility, according to reports.
Swedish medical firm Elekta saw shares surge nearly 8 percent after reporting strong first quarter earnings.
Shares of pharmaceutical giant AstraZeneca, outperformed the broader index, closing down about 2 percent, after it granted Canada's Valeant Pharmaceuticals an exclusive license to develop its psoriasis drug Brodalumab.